TVG to collaborate on novel vaccine development with DiaGen Ai

TVG has recently entered into a Technology Evaluation Agreement with DiaGen Ai, a Canadian startup company formerly known as Proteic. DiaGen was founded in 2021 to develop a proprietary AI engine for protein design, drug discovery and diagnostics for health, wellness, longevity and precision medicine. This collaboration will bring together complimentary approaches to developing novel […]